In tumor progression, CD8+ T cells are the key mediators of cytotoxic effector function, play an important part in the adaptive immunity of the body and are one of the main effector cells of tumor adoptive immunotherapy [51, 52]. This evidence concerns the gene CD8A and neoplasm.